Carenity

What Carenity does

Carenity is a French digital patient platform, legally operated as ELSE CARE SAS and headquartered in Paris, that connects people affected by chronic illness across six countries (France, United Kingdom, Spain, Germany, Italy, and the United States). Founded in 2011 by Michael Chekroun, it positions itself as the first social network dedicated to chronic disease patients and caregivers, and reports more than 500,000 registered members, 1,453,000 forum messages, 78,900 medication reviews, and 300,000 survey participants. The product surface comprises disease-organized community forums, a medication review and rating system, an online survey engine, an editorial Health Magazine, structured disease information sheets, and native iOS and Android applications, with localized content in French, English, Spanish, German, and Italian.

The underlying technology is a web-based patient community platform with mobile clients, content management for editorial health articles, structured data capture for surveys and medication reviews, and country-specific domain infrastructure. The platform maintains a Scientific and Ethics Committee and a public scientific publications track record hosted at pro.carenity.com, lending institutional credibility to its research outputs.

Carenity's business model is data monetization through commissioned research. The patient-facing platform is free, which removes participation barriers and supports broad community growth; revenue is generated by conducting anonymized real-world evidence studies, patient-reported outcomes research, and market surveys on behalf of pharmaceutical and healthcare industry clients. The company is privately held, has not raised institutional venture capital according to available sources, and operates with a team of 11-50 employees. Its go-to-market is community-led and content-led, acquiring patients through SEO, social media (Facebook, Instagram, YouTube), app stores, and partnerships with patient associations, while commercial clients are reached through a B2B sales motion on the professional sub-site.

Name

Carenity

Legal name

ELSE CARE SAS

Website

https://carenity.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Carenity is a Paris-based digital patient platform connecting chronic disease patients and caregivers across six countries, monetizing aggregated patient-reported outcomes and survey data through commissioned real-world evidence studies for pharmaceutical clients.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Industry Studies: Carenity generates revenue by conducting studies and surveys on behalf of pharmaceutical and healthcare industry partners. These are anonymized studies analyzing patient-reported outcomes, medication experiences, and real-world evidence from the platform's member community. The company clearly states this transparency about their funding model on their platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Carenity operates a free digital patient community platform that connects over 500,000 chronic disease patients and caregivers across six countries (France, UK, Spain, Germany, Italy, USA). The platform provides disease-specific forums, medication reviews, and online surveys through which patients generate real-world evidence that Carenity then packages into commissioned studies for pharmaceutical and healthcare industry partners.

Product overview

Carenity is a patient-centered social network platform for people affected by chronic illnesses, comprising six integrated product modules: Forums for peer support discussions organized by disease, Medication Reviews for patient drug feedback, Online Surveys for contributing real-world data to medical research, a Health Magazine with editorial content including articles and expert videos, Disease Information Sheets for medical reference, and Mobile Apps for iOS and Android. The platform connects over 500,000 members across multiple language versions (French, English, Spanish, German, Italian) and serves as a bridge between patients and medical research.

Differentiator

Problem solved

Functional benefit

Products and services

• Carenity Forums Community forums where patients and caregivers share experiences, discuss diseases, and provide mutual support organized by chronic condition.
• Medication Reviews Platform module where patients provide reviews and ratings on medications including effectiveness, side effects, and quality of life impact with aggregated community feedback.
• Online Surveys Patient survey module that collects real-world evidence and patient-reported outcomes to contribute to medical research and healthcare improvements commissioned by industry partners.
• Health Magazine Editorial content module featuring articles on diseases, treatments, expert videos, patient testimonies, nutrition advice, and health rights information.
• Disease Information Sheets Comprehensive disease fact sheets providing patients with medical information about conditions, symptoms, and treatments.
• Carenity Mobile App iOS and Android mobile applications enabling chronic disease patients to access the Carenity community, forums, medication reviews, and health content on the go.

Quantifiable outcome

• 500,000 registered patients sharing health experiences
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Pharmaceutical Industry PartnersprimaryStrategic or Co-development PartnerCarenity's primary business model involves conducting studies and research projects in partnership with pharmaceutical and healthcare industry clients. These partners commission anonymized surveys and data analyses from Carenity's patient community to gather real-world evidence and patient-reported outcomes for drug development and medical research purposes.

Scale indicators5 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• PatientsLikeMe: Patient community platform for chronic conditions with medication tracking, symptom reporting, and research-grade RWE outputs. Direct competitor to Carenity in the patient-community-driven RWE category; now owned by UnitedHealth Group.
• MyHealthTeams: Operates condition-specific social networks (e.g., MyDiabetesTeam, MyMSTeam) for chronic disease patients, monetizing through pharma-sponsored content and RWE. Directly comparable D2C chronic-condition community model with pharma partnerships.
• Inspire: US-based patient community platform partnered with patient advocacy organizations, providing RWE and research recruitment services to life sciences clients. Direct competitor in community-driven RWE for pharma.
• Smart Patients: Patient community platform with a strong focus on oncology and rare diseases, enabling peer learning and clinical trial recruitment. Comparable in providing community + research-enablement services to pharma.
• HealthUnlocked: UK-headquartered health social network with 1M+ members across condition-specific communities, serving both patients and healthcare partners with research and content services. Closely comparable European peer with similar patient community + partner services model.
• MediGuard: Free medication safety and adherence platform where patients report side effects and experiences with drugs. Closely comparable to Carenity's medication review and patient-reported outcomes modules.

Broad incumbents

• Healthline: Major consumer health information and community property (owned by Dotdash Meredith / Roper) covering chronic conditions with a large audience and pharma partnerships. Larger, content-led incumbent adjacent to Carenity's magazine and community model.
• WEGO Health: Larger patient influencer and community network serving life sciences with insights, content, and advisory boards. Broader incumbent offering similar RWE-adjacent services to pharma across more touchpoints than Carenity.

Emerging players

• ClinLife: Clinical trial recruitment and patient engagement platform that surfaces real-world patient data to sponsors. Adjacent peer competing for pharma RWE and patient-recruitment budgets.
• RareConnect: EURORDIS-affiliated rare disease patient community platform serving patients and researchers. Comparable patient community model but narrower therapeutic focus on rare diseases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCtc_T6EnRDC41MPZDM0fNFw
• Facebookfacebook.com/Carenity
• Instagraminstagram.com/carenity_fr
• Xx.com/Carenity

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Carenity